Melissa S. Kampmann’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Sell
36,343
-437
-1% -$29.1K 1.85% 21
2026
Q1
$2.31M Hold
36,780
1.85% 25
2025
Q4
$2.65M Sell
36,780
-560
-1% -$36.2K 1.96% 25
2025
Q3
$2.51M Sell
37,340
-310
-0.8% -$24.5K 1.83% 26
2025
Q2
$3.29M Sell
37,650
-135
-0.4% -$10.6K 2.47% 21
2025
Q1
$2.58M Buy
37,785
+4,450
+13% +$363K 2.04% 27
2024
Q4
$2.59M Sell
33,335
-7,905
-19% -$585K 2.04% 27
2024
Q3
$2.76M Sell
41,240
-45
-0.1% -$3.69K 1.95% 27
2024
Q2
$4.68M Sell
41,285
-413
-1% -$52.2K 3.42% 8
2024
Q1
$5.78M Buy
41,698
+3,533
+9% +$444K 4.16% 4
2023
Q4
$4.74M Buy
38,165
+240
+0.6% +$24.5K 4.06% 4
2023
Q3
$3.54M Buy
+37,925
New +$4.28M 3.41% 9

Other funds holding DXCM

Melissa S. Kampmann's DXCM Position: Q2 2026 in Review

Melissa S. Kampmann reduced its DexCom (DXCM) stake by 1.2% in Q2 2026, selling an estimated $29.1K and leaving 36,343 shares worth $2.45M. The position accounts for 1.85% of the portfolio, ranked #21.

Melissa S. Kampmann first reported a position in DXCM in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.78M in Q1 2024. 462 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Melissa S. Kampmann held 36,343 shares of DexCom worth $2.45M as of Q2 2026.
  • Melissa S. Kampmann sold 437 DexCom shares in Q2 2026, an estimated $29.1K.
  • DexCom made up 1.85% of Melissa S. Kampmann's portfolio in Q2 2026, its #21 holding.
  • Melissa S. Kampmann first reported a position in DexCom in Q3 2023 and has held it in 12 quarters since.
  • Melissa S. Kampmann's DexCom position peaked at $5.78M in Q1 2024.
  • 462 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Melissa S. Kampmann's 13F filing for Q2 2026, filed 29 Jul 2026.